Pharma Journalist - Page 9 of 849 -

argenx Wins FDA Approval for VYVGART Hytrulo Self-Injection

Cingulate Secures $3M Grant to Advance Anxiety Drug CTx-2103 (Buspirone)

FDA Approves Biocon’s Jobevne, Bevacizumab Biosimilar

RedHill Licenses RHB-102 to Hyloris for Global Commercialization, Potentially Worth $60M

Summit Therapeutics Partners with Pfizer to Trial Ivonescimab with ADCs

Mirum’s CTEXLI Tablets FDA-Approved for Cerebrotendinous Xanthomatosis

FDA Accepts BMS’ SBLAs for Opdivo + Yervoy in MSI-High, MMR-D Cancer

EMA Validates Gilead’s Application for Twice-Yearly Lenacapavir as HIV Prevention

Teva and Alvotech Launch SELARSDI Injection in the U.S.

Boehringer’s Zongertinib Gets U.S. FDA Priority Review for HER2-Mutant Advanced NSCLC

FDA Grants ImmunityBio Approval to Supply Recombinant BCG (rBCG) Amid TICE BCG Shortage

Rznomics Inc. Liver Cancer Drug Receives Fast Track Designation

FDA Accepts Dupixent sBLA for Bullous Pemphigoid Treatment under Priority Review